A penetrating injury from shrapnel is a serious obstacle in overcoming battlefield wounds that can ultimately lead to death.Given the high mortality rates due to hemorrhaging, there is an unmet need to quickly self-administer materials that prevent fatality due to excessive blood loss.
With a gelling agent commonly used in preparing pastries, researchers from the Inspired Nanomaterials and Tissue Engineering Laboratory have successfully fabricated an injectable bandage to stop bleeding and promote wound healing.
In a recent article “Nanoengineered Injectable Hydrogels for Wound Healing Application” published in Acta Biomaterialia, Dr. Akhilesh K. Gaharwar, assistant professor in the Department of Biomedical Engineering at Texas A&M University, uses kappa-carrageenan and nanosilicates to form injectable hydrogels to promote hemostasis (the process to stop bleeding) and facilitate wound healing via a controlled release of therapeutics.
“Injectable hydrogels are promising materials for achieving hemostasis in case of internal injuries and bleeding, as these biomaterials can be introduced into a wound site using minimally invasive approaches,” said Gaharwar. “An ideal injectable bandage should solidify after injection in the wound area and promote a natural clotting cascade. In addition, the injectable bandage should initiate wound healing response after achieving hemostasis.”
The study uses a commonly used thickening agent known as kappa-carrageenan, obtained from seaweed, to design injectable hydrogels. Hydrogels are a 3-D water swollen polymer network, similar to Jell-O, simulating the structure of human tissues.
When kappa-carrageenan is mixed with clay-based nanoparticles, injectable gelatin is obtained. The charged characteristics of clay-based nanoparticles provide hemostatic ability to the hydrogels. Specifically, plasma protein and platelets form blood adsorption on the gel surface and trigger a blood clotting cascade.
“Interestingly, we also found that these injectable bandages can show a prolonged release of therapeutics that can be used to heal the wound” said Giriraj Lokhande, a graduate student in Gaharwar’s lab and first author of the paper. “The negative surface charge of nanoparticles enabled electrostatic interactions with therapeutics thus resulting in the slow release of therapeutics.”
The Latest on: Injectable hydrogels
via Google News
The Latest on: Injectable hydrogels
- Multifunctional bioactive Nd-Ca-Si glasses for fluorescence thermometry, photothermal therapy, and burn tissue repairon August 7, 2020 at 11:44 am
On the basis of this consideration, we designed an Nd-Ca-Si bioglass system and injectable glass/alginate composite hydrogel with photothermal performance, fluorescence temperature–monitoring ...
- Ocular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q2 2020 Results - Earnings Call Transcripton August 7, 2020 at 9:40 am
Q2 2020 Earnings Conference Call August 07, 2020, 08:30 ET Company Participants Donald Notman - CFO Antony Mattessich - President, CEO & Director Michael Goldstein - Chief Medical Officer Conference ...
- Ocular Therapeutix™ Reports Second Quarter 2020 Financial Results and Business Updateon August 7, 2020 at 4:34 am
OTX-TKI is a bioresorbable, hydrogel implant incorporating axitinib ... will receive a 400 µg dose and an anti-VEGF induction injection (cohort 3b = 6 patients). The Company plans to provide ...
- Ocular Therapeutix™ Reports Second Quarter 2020 Financial Results and Business Updateon August 7, 2020 at 4:23 am
Amended collaboration with Regeneron for the development of a suprachoroidal injection formulation of ... OTX-TKI is a bioresorbable, hydrogel implant incorporating axitinib, a small molecule ...
- Ocular Therapeutix(TM) Reports Second Quarter 2020 Financial Results and Business Updateon August 7, 2020 at 4:21 am
Ocular Therapeutix(TM) Reports Second Quarter 2020 Financial Results and Business Update ...
- Ocular Therapeutix™ Reports Second Quarter 2020 Financial Results and Business Updateon August 7, 2020 at 4:15 am
Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative the ...
- Medical “Vampire” Robot Seeks Human Vein, Inserts Needle, Sucks Bloodon July 30, 2020 at 10:56 am
A clinician does the setup of general positioning of the machine with respect to the subject’s arm, sterilizing/wiping the target zone, applying ultrasound hydrogel and selecting the target vein ...
via Bing News